Caricamento...
Gonadotropin-releasing hormone agonist use in men without a cancer registry diagnosis of prostate cancer
BACKGROUND: Use of gonadotropin-releasing hormone (GnRH) agonists has become popular for virtually all stages of prostate cancer. We hypothesized that some men receive these agents after only a limited work-up for their cancer. Such cases may be missed by tumor registries, leading to underestimates...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2008
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2483971/ https://ncbi.nlm.nih.gov/pubmed/18620606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6963-8-146 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|